Back to search

Article

An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2

2021-03-12

Abstract excerpt

The novel and highly pathogenic coronavirus (SARS-CoV-2) remains a public health threat worldwide. SARS-CoV-2 enters human host lung cells via its spike protein binding to angiotensin-converting enzyme 2 (ACE2) in a process critical dependent on host protease-mediated fusion event. Thus, effective targeted therapies blocking the first step of viral fusion and cellular entry remains a critical unmet medical need to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8abc0109-4866-519e-b213-9ac3ecf0f812
DOI
10.1101/2021.03.11.434589
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2DOI 10.1101/2021.03.11.434589
Select a neighboring publication to make it the new centre.